<DOC>
	<DOCNO>NCT01799408</DOCNO>
	<brief_summary>To evaluate effect intra-articular corticosteroid injection ( IACI ) depot preparation betamethasone hypothalamic-pituitary-adrenal ( HPA ) axis , patient osteoarthritis knee</brief_summary>
	<brief_title>Intra-articular Betamethasone Hypothalamic-pituitary-adrenal Axis</brief_title>
	<detailed_description>Consecutive patient attend rheumatology orthopedic clinic osteoarthritic knee pain , respond satisfactorily medical physical therapy allocate group-1 consent give IACI 6 mg betamethasone acetate/betamethasone sodium phosphate . Following completion part , consecutive age- sex-matched patient allocate group-2 give intra-articular injection 60 mg sodium hyaluronate . Just prior knee injection 1 , 2 , 3 , 4 8 week later , patient 1 Âµg adrenocorticotropin hormone ( ACTH ) stimulation test . Secondary adrenal insufficiency ( SAI ) define level less 18 ng/ml rise &lt; 7 ng/ml serum cortisol , 30 minute follow ACTH stimulation test .</detailed_description>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Osteoarthritis knee Had steroid last 3 month . Allergic steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>